Johnson & Johnson to Acquire Abiomed : vimarsana.com

Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, and Abiomed (NASDAQ: ABMD), a world leader in breakthrough heart, lung and kidney support technologies, today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire ...

Related Keywords

United States , Massachusetts , Michael Bodner , Johnson Plaza , Michaelr Minogue , Johnson Medtech , Joaquin Duato , Abiomed Breethe , Ashley Mcevoy , Johnson , Biosense Webster , Office Of The Corporate , Jp Morgan Securities , Exchange Commission , Abiomed , Sullivan Cromwell , Goldman Sachs Co , Swaine Moore , Abiomed Inc , Strengthens Johnson , Medtech Business , Bring Lifesaving Innovations , More Patients , Enhance Johnson , Long Term Sales , Earnings Growth , Adjusted Earnings , Discuss Details , Chief Executive Officer , Executive Vice President , Worldwide Chairman , Chief Executive , Merger Sub , Andrew Greenfield , Chief Commercial Officer , Interventional Cardiovascular , Abbott Vascular , Worldwide President , Biosense Webster Electrophysiology , Impella Connect , Automated Impella Controller , Hart Scott Rodino Antitrust Improvements Act , Annual Report , Note Regarding Forward Looking , Quarterly Reports , Corporate Secretary , Stone Johnson , New Brunswick ,